JPMorgan Chase & Co.'s Chief Executive Jamie Dimon told analysts on Wednesday he plans to stay in the job "for a few more ...

Bruce Cozadd, the retiring CEO of Jazz Pharmaceuticals, has outlined a developing oncology pipeline at the company. Speaking ...

JPMorgan Chase management disabled comments on an internal webpage where the policy was announced, according to the Wall ...

Zimmer Biomet expressed its optimism that the company will strengthen its market return in 2025 during the JP Morgan ...

The bank – the largest in the US with more than 300,000 employees worldwide – is expected to announce the change in the next ...

AbbVie executives said they have high hopes for Skyrizi and Rinvoq in the inflammatory bowel disease market after Humira ...

The financial giant has disgruntled workforce and has a potential unionization on its hands as it forces staff into the ...

The bank said profit rose 50% to $14 billion in the fourth quarter as noninterest expenses fell 7% from a year earlier.

In a report released today, Glenn Schorr from Evercore ISI maintained a Buy rating on JPMorgan Chase & Co. (JPM – Research Report), with a ...

Amgen CEO Robert Bradway said the company's obesity drug could find its space in the market due to once-monthly dosing and ...

JPMorgan Chase & Co. finished off 2024 with a profit that beat analyst estimates as the U.S.'s largest bank reported fourth-quarter earnings of $4.81 a share, well ahead of the FactSet consensus ...

JPMorgan Chase reported stronger-than-expected Q4 earnings, with net interest income staying flat and investment banking ...